Literature DB >> 12586632

Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis.

Rosalie M Luiten1, Jérome Péne, Hans Yssel, Hergen Spits.   

Abstract

Human somatic cells have a limited life span in vitro. Upon aging and with each cell division, shortening of telomeres occurs, which eventually will lead to cell cycle arrest. Ectopic hTERT expression has been shown to extend the life span of human T cells by preventing this telomere erosion. In the present study, we have shown that ectopic hTERT expression extends the life span of CD4+ T helper type 1 or 2 and regulatory T-cell clones and affected neither the in vitro cytokine production profile nor their specificity for antigen. In mixed cell cultures, ectopic hTERT-expressing clones were found to expand in greater numbers than untransduced cells of the same replicative age. This ectopic hTERT-induced growth advantage was not due to an enhanced cell division rate or number of divisions following T-cell receptor-mediated activation, as determined in carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeling experiments. Moreover, the susceptibility to activation-induced cell death of both cell types was similar. However, cultures of resting hTERT-transduced T cells contained higher frequencies of Bcl-2-expressing cells and lower active caspase-3-expressing cells, compared with wild-type cells. Furthermore, hTERT-transduced cells were more resistant to oxidative stress, which causes preferential DNA damage in telomeres. Taken together, these results show that ectopic hTERT expression not only protects proliferating T cells from replicative senescence but also confers resistance to apoptosis induced by oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586632     DOI: 10.1182/blood-2002-07-2018

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  Immortalization of human and rhesus macaque primary antigen-specific T cells by retrovirally transduced telomerase reverse transcriptase.

Authors:  Eugene V Barsov
Journal:  Curr Protoc Immunol       Date:  2011-11

2.  Telomerase is involved in IL-7-mediated differential survival of naive and memory CD4+ T cells.

Authors:  Yinhua Yang; Jie An; Nan-ping Weng
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

3.  Testing for HLA/peptide tetramer-binding to the T cell receptor complex on human T lymphocytes.

Authors:  Pauline Weder; Ton N M Schumacher; Hergen Spits; Rosalie M Luiten
Journal:  Results Immunol       Date:  2012-05-10

Review 4.  Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases.

Authors:  Michael Patrick; Nan-Ping Weng
Journal:  Cell Immunol       Date:  2019-09-19       Impact factor: 4.868

5.  Does telomerase reverse transcriptase induce functional de-differentiation of human endothelial cells?

Authors:  Yvonne Baumer; Dorothee Funk; Burkhard Schlosshauer
Journal:  Cell Mol Life Sci       Date:  2010-03-30       Impact factor: 9.261

6.  Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor.

Authors:  Xun Jin; Samuel Beck; Young-Woo Sohn; Jun-Kyum Kim; Sung-Hak Kim; Jinlong Yin; Xumin Pian; Sung-Chan Kim; Yun-Jaie Choi; Hyunggee Kim
Journal:  Exp Mol Med       Date:  2010-08-31       Impact factor: 8.718

7.  Lung alveolar integrity is compromised by telomere shortening in telomerase-null mice.

Authors:  Jooeun Lee; Raghava Reddy; Lora Barsky; Jessica Scholes; Hui Chen; Wei Shi; Barbara Driscoll
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-24       Impact factor: 5.464

Review 8.  Telomerase inhibition in cancer therapeutics: molecular-based approaches.

Authors:  A P Cunningham; W K Love; R W Zhang; L G Andrews; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 9.  Principles of adoptive T cell cancer therapy.

Authors:  Carl H June
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

10.  Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance.

Authors:  Jue Lin; Elissa Epel; Joshua Cheon; Candyce Kroenke; Elizabeth Sinclair; Marty Bigos; Owen Wolkowitz; Synthia Mellon; Elizabeth Blackburn
Journal:  J Immunol Methods       Date:  2009-10-21       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.